Agilent AAV Workflow Summit: From Identity Confirmation to Aggregate Analysis

There is a lot of interest in adeno-associated viruses (AAVs), especially as vectors for gene therapy. AAVs are good candidates for this application due to their ability to infect both dividing and non-dividing cells without eliciting a strong immune response. Before AAV products can be released, they require unambiguous identification.

Agilent delivers total solutions for efficient AAV characterization and analysis while monitoring critical quality attributes.

This virtual event will provide you with expertise on:

• LC/MS workflows for the identification of AAV capsid proteins and impurities
• SEC workflows for aggregate and fragment analysis
• IEX workflows to determine empty/full capsid ratios

Confirmed presentations

• Introduction to the Analysis of Adeno-associated Virus Particles
• AAV Capsid Protein Analysis using high resolution LC/MS
• Multiple Peptide-Based Attributes of AAV with a Comprehensive LC/MS Method
• Analytics of AAV based Gene Therapeutics

Who should attend?

• Analytical development scientists
• CDMO and CRO lab personnel
• Biopharmaceutical scientists in process development